AiCuris Anti-infective Cures GmbH

Since it has become difficult for many biopharmaceutical companies to raise money during the past year and a half, several firms have been forced to cut costs to make remaining cash balances last long

Organizers of a new European initiative to speed up the search for potential treatments for COVID-19 and future coronavirus threats have framed the project as an “unprecedented” exercise in cooperatio

Sanofi and GSK ‘Happy To Lose’ COVID-19 Vaccine Race Sanofi and GlaxoSmithKline plc , two big pharma firms working together on a potential vaccine against the coronavirus, said they would not be di

Royalty Pharma has years of success behind it and reached new heights with a record-setting initial public offering of $2.18bn on 16 June – followed by its share price soaring during its first day on